Skip to main content

Markets

Pfizer Touts Weight Loss Drug With Similar Results to Ozempic

Published

May 22, 2023

A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.

No transcript available

More in this Series

See all

My Quotes
My European Quotes
Watchlist

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

/

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

/

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.

/